Picture of Amphastar Pharmaceuticals, logo

AMPH Amphastar Pharmaceuticals, News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

Amphastar Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 96 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of $1.15.  The mean expectation of
five analysts for the quarter was for earnings of 99 cents per
share. Wall Street expected results to range from 89 cents
to $1.13 per share.
    * Revenue rose 5.9% to $191.21 million from a year ago;
analysts
expected $194.69 million. 
    * Amphastar Pharmaceuticals Inc's reported EPS for the
quarter was
78 cents​.
    * The company reported quarterly net income of $40.43
million.
    * Amphastar Pharmaceuticals Inc shares had risen by 6.2%
this
quarter and lost 16.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.8%
in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $55.00 
This summary was machine generated from LSEG data November 7 at
04:04 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.99                          
 Jun. 30 2024      0.77                          
 Mar. 31 2024      0.96           1.04           Beat
 Dec. 31 2023      0.93           0.88           Missed

Recent news on Amphastar Pharmaceuticals,

See all news